Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-03
2007-04-03
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S506000, C546S335000, C560S019000, C560S125000, C560S128000, C560S016000, C560S147000, C564S241000
Reexamination Certificate
active
10480805
ABSTRACT:
Nitro-oxyderivative compounds or salts thereof having the following general formula (I): A—(B)b0—(C)c0—NO2wherein: c0 is an integer and is 0 or 1, b0 is an integer and is 0 or 1, A=R—T1—, wherein R is the radical of an analgesic drug for the chronic pain, in particular for the neuropathic pain; B is such that its precursor is selected from anminoacids, hydroxyacids, polyalcohols, compounds containing at least one acid function; C is a bivalent radical containing an aliphatic, heterocyclic or aromatic radical.
REFERENCES:
patent: 5844696 (1998-12-01), Masia et al.
patent: 6187338 (2001-02-01), Caruso et al.
patent: 95/09831 (1995-04-01), None
patent: WO 95 30641 (1995-11-01), None
patent: WO 96 19233 (1996-06-01), None
patent: 97/16405 (1997-05-01), None
patent: WO 98 09948 (1998-03-01), None
patent: WO 00 06567 (2000-02-01), None
patent: WO 00 44705 (2000-08-01), None
patent: WO 00 54773 (2000-09-01), None
patent: WO 00 66582 (2000-11-01), None
patent: 00/76958 (2000-12-01), None
patent: 01/12584 (2001-02-01), None
patent: WO 01 83490 (2001-11-01), None
patent: WO 02 30866 (2002-04-01), None
patent: WO 02 30867 (2002-04-01), None
Radomski et al., “The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide”, BR. J. Pharmac. (1987), 92, pp. 639-646.
Bennett et al., “A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man”, Pain, 33 (1988), pp. 87-107.
Xu et al., “Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury” Pain, 48 (1992), pp. 279-290.
Hao et al., “Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists”, Pain, 66, (1996), pp. 279-285.
Martindale, The Extra Pharmacopoeia 13thEdition, p. 374.
Del Soldato Piero
Ongini Ennio
Arent & Fox LLP
McKane Joseph K.
Nicox S.A.
Shiao Robert
LandOfFree
Drugs for chronic pains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drugs for chronic pains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs for chronic pains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760153